EndoGene.Bio
endogene.bioLocations
Île-de-France, France · Paris, France · Paris, France
industry
Biotechnology
Size
1 - 10 employees
Stage
Other
founded in
2022
Endogene.bio was founded to solve the lack of molecular data that keeps endometriosis a clinical black box. By analyzing key cells in menstrual blood, the company delivers tissue-level insights with the convenience of a liquid biopsy. Its platform integrates a proprietary database of single-cell epigenetics and transcriptomics with OMICS ML advanced algorithms to enable earlier diagnosis, patient stratification, and targeted drug discovery. With proprietary datasets, clinical validation, and pharma interest, Endogene.bio is unlocking molecular medicine in a €180B+ women’s health market.
Something looks off?Open jobs at EndoGene.Bio
On-site & Remote
Job function
Seniority
Salary